Fromen Research Group
Engineering Particle-Lung Interactions
Welcome to the Fromen Research Group! Our research is all about the lungs. We seek to advance understanding of the unique environment of the airways, from fluid dynamics to mucosal immunology. Armed with this foundation, we develop new therapeutics and analytical tools to treat a range of diseases specific to the lungs.
As we head into the fall 2021 semester, we have a few important notes to wrap up the summer:
Congratulations to PhD candidate Bader Jarai for winning 1st Place in the Technology Session Lightning Talks at the v-NERIC Conference this past week! His talk was titled: “Internalization of Nanoparticles Enhances the Survival of Primary Macrophages”. You can access his talk and other talks from the INBRE NERIC Meeting until mid September here. Congrats Bader!!
A HUGE congratulations to PhD candidate Emily Kolewe for receiving an NIH NHLBI F31 Fellowship!!! Her project is titled “Dynamic, Cellularized, 3D Printed Model Development for Aerosol Targeting in Pediatric JORRP Patients”. The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (F31) is to enable promising predoctoral students to obtain individualized, mentored research training from outstanding faculty sponsors while conducting dissertation research. Emily will have the opportunity to train with our collaborator, Dr. Jena Briddell, at Nemours/AI Du Pont Hospital for Children while developing better pediatric models for inhaled drug delivery. Congrats Emily!!
Finally, the FROMEN LAB IS HIRING! We are looking for outstanding postdoctoral fellows to join our in vitro lung modeling project and our mucosal therapeutic immune engineering project. You can read more about the two positions and how to apply here:
We’ll be looking to recruit new first year PhD students and undergraduate researchers as well! Stay tuned for more updates as our team evolves and hope everyone has a great fall 2021 semester!
The Fromen lab is enjoying a busy and productive summer as we enter into the “new normal”. A few congratulations are in order:
Congrats to Teresa Cruz on passing her Biology Comp Exam!
Congrats to Bader Jarai and Zach Stillman on their recent publication in J Mater Chem B: Hydrogel nanoparticle degradation influences the activation and survival of primary macrophages. This work is part of a special Emerging Investigators issues from the journal. You can read the article here: https://doi.org/10.1039/D1TB00982F
Also, we are excited to announce that the Fromen lab has been awarded an NIH NIGMS R35 MIRA award! The grant is titled “Multiscale considerations for immune engineering at mucosal interfaces” and provides the Fromen lab 2 million dollars over 5 years. The MIRA mechanism funds a the research program of a promising early stage investigator (ESI), with a goal of providing the team more flexibility to pursue new ideas and opportunities as they arise during the course of research because the award is not tied to specific aims. With this support, the Fromen lab will study ways to overcome challenges therapeutics face at mucosal interfaces in order to design better medicines (think inhalable vaccines). The project areas align with those of the Fromen lab: developing new models of mucosal transport and designing new mucosal medicines.
Congrats to Prof Fromen and the entire Fromen lab!
Stay tuned for more excited updates from the Fromen lab and upcoming open positions!
Click for more Fromen lab news!